XLO - Xilio Therapeutics Inc
IEX Last Trade
1.1
0.050 4.545%
Share volume: 230,539
Last Updated: Fri 10 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.88%
PREVIOUS CLOSE
CHG
CHG%
$1.05
-0.02
-0.02%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-14 | 2024-08-08 | 2024-11-07 | |
| Assets | ||||
| Total Assets | 82.609 M | 89.873 M | 74.658 M | |
| Current Assets | 69.185 M | 78.008 M | 63.309 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 33.980 M | 74.949 M | 61.259 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 5.542 M | 5.137 M | 4.845 M | |
| Other Assets | 7.882 M | 6.728 M | 6.504 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 82.609 M | 89.873 M | 74.658 M | |
| Total liabilities | 56.844 M | 56.457 M | 53.684 M | |
| Total current liabilities | 31.582 M | 38.641 M | 38.022 M | |
| Accounts Payable | 746.000 K | 1.264 M | 972.000 K | |
| Other liabilities | 7.863 M | 7.566 M | 7.263 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 7.863 M | 7.566 M | 7.263 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 25.765 M | 33.416 M | 20.974 M | |
| Common stock | 368.480 M | 390.056 M | 391.634 M | |
| Retained earnings | -342.715 M | -356.640 M | -370.660 M |